🇺🇸 FDA
Patent

US 6521212

Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation

expired A61KA61K31/5575A61K9/0078

Quick answer

US patent 6521212 (Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation) held by United Therapeutics Corporation expires Mon Feb 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
United Therapeutics Corporation
Grant date
Tue Feb 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/5575, A61K9/0078, A61P, A61P11/00